A comprehensive prognostic index to predict survival based on multiple comorbidities: A focus on breast cancer

Medical Care

Volumn 37, Issue 6, 1999, Pages 601-611

  Fleming, Steven T ^a   Rastogi, Amita ^a   Dmitrienko, Alexei ^b   Johnson, Kjell D ^a  

^a Health Services Management   (United States)

^b Stat and Mathematical Sciences   (United States)

Author keywords

Breast neoplasms; Comorbidity; Comorbidity index; Prognostic index; Proportional hazard models; Survival rate

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; BREAST TUMOR; CANCER STAGING; CAUSE OF DEATH; COMORBIDITY; FEMALE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; INSURANCE; MEDICAL RECORD; MEDICARE; MORTALITY; PREDICTION AND FORECASTING; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REGISTER; REPRODUCIBILITY; RISK FACTOR; STATISTICS; SURVIVAL; UNITED STATES;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CAUSE OF DEATH; COMORBIDITY; FEMALE; HUMANS; INSURANCE CLAIM REPORTING; KENTUCKY; MEDICAL RECORD LINKAGE; MEDICARE; NEOPLASM STAGING; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; UNITED STATES;

EID: 0033143455     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-199906000-00009     Document Type: Article

References (35)

1. Fleming ST, Hicks LL, Bailey RC. Interpreting the health care financing administration's mortality statistics. Med Care 1995;33(2):186.
2. Pompei P, Charlson ME, Douglas G. Clinical assessments as predictors of one year survival after hospitalization: Implications for prognostic stratification. J Clin Epidemiol 1988;41(3):275.
3. Charlson ME, Pompei P, Ales KL, McKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chron Dis 1987;40(50):373
4. Charlson ME, Szatrowksi TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47(11):1245.
5. D'Hoore W, Sicotte C, Tilquin C. Risk adjustment in outcome assessment: The Charlson Comorbidity Index. Meth Inform Med 1993;32(5):382.
6. Poses, RM, McClish DK, Smith WR, Bekers C, Scott WE. Prediction of survival of critically ill patients by admission comorbidity. J Clin Epidemiol 1996;49(7):743.
7. Cleves MA, Sanchez N, Draheim M. Evaluation of two competing methods for calculating Charlson's comorbidity index when analyzing short-term mortality using administrative data. J Clin Epidemiol 1997;50(8):903.
8. Melfi C, Holleman E, Arthur D, Katz B. Selecting a patient characteristics index for prediction of medical outcomes using administrative claims. J Clin Epidemiol 1995;48(7):917.
9. Ghali WA, Hall RE, Rosen AK, Ash AS, Moskowitz MA. Searching for an improved clinical comorbidity index for use with ICD-9-CM administrative data. J Clin Epidemiol 1996;49(3):273.
10. Rothenberg B, Mooney C, Curtis L. Measures of severity of illness and comorbidity. In: Andresen E, Rothenberg B, Zimmer JG, eds. Assessing the health status of older adults. New York: Springer Publishing Company, 1997.
11. Fleming ST, McMahon LF Jr, DesHarnais SI, Chesney JD, Wroblewski RT. The measurement of mortality: A risk-adjusted variable time window approach. Med Care 1991;29(9):815.
12. DesHarnais SI, Chesney JD, Wroblewski RT, Fleming ST, McMahon LF Jr. et al. The Risk-Adjusted Mortality Index: A new measure of hospital performance. Med Care 1988;26(12):1129.
13. Pompei P, Charlson ME, Ales K, MacKenzie CR, Norton M. Relating patient characteristics at the time of admission to outcomes of hospitalization. J. Clin Epidemiol 1991;44(10):1063.
14. Iezzoni LI. Dimensions of Risk. In: Risk adjustment for measuring health care outcomes. Ann Arbor, MI: Health Administration Press, 1994.
15. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives. J Clin Epidemiol 1993;46(10):1075.
16. SAS Technical Report. SAS/STAT software. Changes and enhancements. Cary, NC: SAS Institute, 1996.
17. National Cancer Institute. SEER Cancer Incidence Public-Use Database, 1973-1995, April 1998.
18. Haybittle JL, Barney RW, Elston CW, Johnson J, Doyle PJ, Campbell FC, et al. A prognostic index in primary breast cancer. Br J Cancer 1982;45(3):361.
19. Galea MH, Blarney RW, Elston CE, Ellis IO. The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 1992;22(3):207.
20. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63(1):181.
21. Dorr FA. Prognostic factors observed in current clinical trials. Cancer Supp 1992;71(6):2163.
22. Greenfield S, Blanco DM, Elashoff RM, Aranow HV. Development and testing of a new index of comorbidity. Clin Res 1987;35(2):346A.
23. Fleming ST, Blake RL, Jr. Patterns of comorbidity in elderly patients with multiple sclerosis. J Clin Epidemiol 1994;47(10):1127.
24. Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of coexistent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement: Comorbidity and outcomes after hip replacement. Med Care 1993;31(2):141.
25. Havlik RJ, Yancik R, Long S, Ries L, Edwards B. The National Institute on Aging and the National Cancer Institute SEER collaborative study on comorbidity and early diagnosis of cancer in the elderly. Cancer 1994;74(7 Suppl):2101.
26. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chron Dis 1974;27(7-8):387.
27. Krousel-Wood MA, Re RN, Abdoh A. The use of three comorbidity indices in predicting mortality from TURP vs open prostatectomy (Abstract). Clin Res 1994;42(2):248A.
28. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45(6):613.
29. Romano PS, Roos LL, Jollis JG. Further evidence concerning the use of a clinical comorbidity index with ICD-9-CM administrative data. J Clin Epidemiol 1993;46(10):1085.
30. Everitt BS. Statistical methods for medical investigations 2nd Edition. New York: Halsted Press, an imprint of John Wiley & Sons, 1994.
31. Bergman L, Dekker G, Kerkhoff EHM van, Peterse HL, Dongen JA van. Influence of age and comorbidity on treatment choice and survival in elderly patients with breast cancer. Breast Cancer Research and Treatment. 1991;18(3):189.
32. Chu KC, Tarone RE, Kessler LG, Ries LAG, Hankey BF, Miller BA, Edwards BK. Recent trends in US breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 1996;88(21):1571.
33. Yancik R, Ries LG, Yates JW. Breast cancer in aging women: A population-based study of contrasts in stage, surgery, and survival. Cancer 1989;63(5):976.
34. Costanza ME, Annas GJ, Brown ML, Cassel CK, Champion V, Cohen HJ, et al. Supporting state ments and rationale. J Gerontol 1992;47:7.
35. Greenfield S, Aronow HU, Elashoff RM, Watanabe D. Flaws in mortality data: The hazards of ignoring comorbid disease. JAMA 1988;260(15):2253.